Clinical Trials Directory

Trials / Unknown

UnknownNCT06031311

Pulmonaryhypertension in Copd at Different Levels of Smoking

Clinical Characteristics and Predictors of Pulmonary Hypertension in COPD at Different Levels of Smoking

Status
Unknown
Phase
Study type
Observational
Enrollment
138 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers

Summary

To identify Predictors of pulmonary hypertension in COPD patients and its relation to different levels of smoking

Detailed description

COPD is a heterogeneous lung condition characterized by chronic respiratory symptoms (dyspnea, cough, expectoration and/or exacerbations) due to abnormalities of the airways (bronchitis, bronchiolitis) and/or alveoli (emphysema) that cause persistent, often progressive, airflow obstruction.It is also the most common cause of deaths in patients with chronic respiratory disease, the fatality rate in USA is 0.41%.Pulmonary Hypertension is the most common serious complication in COPD patients ; which occurs in up to 30% of patients and increases the mortality rate.Smoking is the leading cause of chronic obstructive pulmonary disease (COPD) Smoking is also a trigger for COPD flare-ups.Smoking damages the air sacs, airways, and the lining of your lungs. Injured lungs have trouble moving enough air in and out, so it's hard to breathe

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEchocardiography and HRCTEchocardiography:is non invasive and easily accessible tool in the diagnosis of any patient with suspected PH.HRCT: is a non-invasive and easily accessible tool to detect pulmonary hypertension in COPD patients.

Timeline

Start date
2023-10-01
Primary completion
2024-10-01
Completion
2024-12-01
First posted
2023-09-11
Last updated
2023-09-14

Source: ClinicalTrials.gov record NCT06031311. Inclusion in this directory is not an endorsement.